Related items

Pfizer selected Denmark as the site of the largest vaccine registry study ever undertaken, demonstrating how Europe can attract world-leading life sciences investment when the right conditions are in place. Beginning in 2024, Pfizer partnered with researchers at the Center for Translational Cardiology and Pragmatic Randomized Trials at Herlev-Gentofte Hospital in Copenhagen to assess whether its respiratory syncytial virus vaccine could reduce hospitalisations in adults. Denmark’s innovation-friendly environment, national digital mailbox eBoks and world-class health registries enabled researchers to invite almost the entire adult population to take part, helping recruit more than 500,000 participants. Study materials were made available online, allowing participants to provide informed consent from home, while health registries supported comprehensive tracking and analysis. This milestone shows how strong public-private collaboration and a supportive policy framework can help Europe deliver clinical research at scale and improve health outcomes for citizens. Read the full story on Invested in Europe. 

How can Europe strengthen its digital resilience while remaining open to the partnerships that drive AI innovation? On Wednesday, 17 June, Malte Lohan, CEO, AmCham EU, addressed this at a conference organised by the Cypriot Presidency of the Council of the EU in Nicosia, Cyprus. Discussions focused on how Europe can build a more resilient digital ecosystem while remaining an attractive destination for investment and innovation. Mr Lohan underlined that secure supply chains and trusted partnerships are essential to Europe’s AI competitiveness. He also highlighted the role of US businesses as committed partners in helping Europe build and compete globally, while stressing the need for balanced policies that strengthen resilience and give companies the confidence to invest in Europe.

Predictability in EU-US relations, Europe’s competitiveness agenda and the future of the Single Market were centre stage during AmCham EU’s Executive Council Spring Plenary on Monday, 8 and Tuesday, 9 June. Our senior business leaders met with EU, US and Member State policymakers to discuss the pressures shaping investment decisions in Europe. The group engaged with the following officials: Tomas Baert, Trade Adviser in the Cabinet of European Commission President Ursula von der Leyen; Thomas Hans Ossowski, German Ambassador to the EU; Andrius Kubilius, European Commissioner for Defence and Space; Roberta Metsola, President of the European Parliament and Andrew Puzder, US Ambassador to the EU.